Senior insider sale
See Remarks at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$12.60M
171.08K shares
What this filing means
KUMAR NEIL plans to sell 171.08K shares of BRIDGEBIO PHARMA, INC. valued at approximately $12.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/19/2026ACC: 0001950047-26-008424
DirectorOfficer· See Remarks
Since Jun 2019
171.08K
Shares to sell
$12.60M
Approx. market value
30K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Conversion Management Incentive Units
N/A
3/26/2016
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2016 | Conversion Management Incentive Units N/A | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
34.98K
Market value
$2.89M
8/18/2026
—Completed
Units to sell
20K
Market value
$1.36M
6/5/2026
—Completed
Units to sell
20K
Market value
$1.36M
6/5/2026
—Completed
Units to sell
20K
Market value
$1.35M
6/4/2026
—Completed
Units to sell
20K
Market value
$1.35M
6/4/2026
—Completed
Units to sell
26.10K
Market value
$1.81M
5/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$2.49M
8/19/2026
Total
Units
171.08K
Value
$12.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2026 | 34.98K | $2.89M | — | Completed |
6/5/2026 | 20K | $1.36M | — | Completed |
6/5/2026 | 20K | $1.36M | — | Completed |
6/4/2026 | 20K | $1.35M | — | Completed |
6/4/2026 | 20K | $1.35M | — | Completed |
5/21/2026 | 26.10K | $1.81M | — | Completed |
| Planned — Approximate Date | ||||
8/19/2026 | 30K | $2.49M | NASDAQ | Planned |
| Total | 171.08K | $12.60M | ||